The Pennant Group (NASDAQ:PNTG) Price Target Raised to $37.00 at Oppenheimer

The Pennant Group (NASDAQ:PNTGGet Free Report) had its price objective raised by equities research analysts at Oppenheimer from $34.00 to $37.00 in a report released on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price objective suggests a potential upside of 12.53% from the company’s current price.

A number of other equities research analysts have also recently weighed in on PNTG. Truist Financial lifted their price objective on The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Stephens reissued an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a research note on Wednesday, October 9th. Finally, Royal Bank of Canada raised their price objective on shares of The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a research note on Wednesday, October 23rd.

Get Our Latest Stock Report on The Pennant Group

The Pennant Group Trading Up 2.8 %

The Pennant Group stock traded up $0.88 during trading on Friday, reaching $32.88. 53,609 shares of the company were exchanged, compared to its average volume of 197,839. The Pennant Group has a 52-week low of $11.95 and a 52-week high of $37.13. The company has a market capitalization of $996.59 million, a P/E ratio of 52.19, a PEG ratio of 3.32 and a beta of 2.02. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.12 and a quick ratio of 1.12. The stock’s 50 day simple moving average is $33.82 and its two-hundred day simple moving average is $28.34.

The Pennant Group (NASDAQ:PNTGGet Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. The Pennant Group had a return on equity of 13.74% and a net margin of 3.16%. The firm had revenue of $168.75 million for the quarter, compared to the consensus estimate of $156.71 million. On average, equities research analysts expect that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PNTG. 8 Knots Management LLC lifted its stake in The Pennant Group by 34.0% in the first quarter. 8 Knots Management LLC now owns 2,462,553 shares of the company’s stock worth $48,340,000 after acquiring an additional 625,061 shares during the last quarter. Sei Investments Co. lifted its stake in The Pennant Group by 679.7% in the first quarter. Sei Investments Co. now owns 136,026 shares of the company’s stock worth $2,670,000 after acquiring an additional 118,581 shares during the last quarter. Grandeur Peak Global Advisors LLC purchased a new position in The Pennant Group in the first quarter worth approximately $2,225,000. Vanguard Group Inc. lifted its stake in The Pennant Group by 4.3% in the first quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company’s stock worth $36,505,000 after acquiring an additional 77,052 shares during the last quarter. Finally, Federated Hermes Inc. lifted its stake in The Pennant Group by 600.0% in the second quarter. Federated Hermes Inc. now owns 54,045 shares of the company’s stock worth $1,253,000 after acquiring an additional 46,324 shares during the last quarter. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Articles

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.